FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080734587> ?p ?o ?g. }

• W2080734587 endingPage "1606" @default.
• W2080734587 startingPage "1599" @default.
• W2080734587 abstract "Study objective The purpose of this study is to determine factors, including laboratory data, related to the relapse of bronchiolitis obliterans organizing pneumonia (BOOP). Design Retrospective study. Setting and Patients The medical files of Fukuoka University Hospital and Nishi Fukuoka Hospital patients from 1984 to 1996 were reviewed, and 18 cases of BOOP that had been diagnosed using transbronchial or open lung biopsy were selected for evaluation. Measurements The 18 cases were put into two groups composed of 7 patients who relapsed and 11 who did not relapse. Their clinical symptoms and laboratory data at first admission, including hemograms, blood chemistry tests, and pulmonary function tests were compared. Patients with or without associated diseases, such as collagen vascular diseases, were compared using the same parameters in order to examine the relationship between the associated diseases and BOOP relapse. Results The serum levels of total protein and albumin in patients who relapsed were significantly lower than in patients who did not relapse, respectively: 5.8 (range, 4.4 to 6.2) vs 6.3 (range, 4.5 to 6.8) g/dL, p < 0.05; and 2.9 (range, 2.5 to 3.4) vs 3.7 (range, 2.8 to 4.3) g/dL, p < 0.01. Levels of serum albumin in BOOP patients with associated diseases, however, were significantly lower than in those without associated diseases, respectively: 2.95 (range, 2.5 to 3.9) vs 3.65 (range, 2.8 to 4.3) mg/dL, p < 0.05. The fall in serum albumin levels in patients who relapsed, therefore, was probably due to associated diseases. The fact that 5 of 8 patients with associated diseases relapsed but only 2 of 10 without associated diseases relapsed suggests that a relationship exists between associated diseases and the prognosis of BOOP, although this finding was not statistically significant because of the small number of cases and the heterogeneity of the associated diseases. The most striking observation was that Pao2 levels in patients who relapsed were significantly lower than in those who did not, respectively: 55.4 (range, 39.9 to 73.2) vs 78.0 (range, 48.4 to 89.4) mm Hg, p < 0.05. However, Pao2 levels were not statistically different between patients with and without associated diseases, respectively: 66.0 (range, 45.4 to 78.8) vs 71.4 (range, 39.9 to 89.4) mm Hg. Conclusions The severity of hypoxemia at first medical examination may be an important determinant for the subsequent BOOP relapse. The purpose of this study is to determine factors, including laboratory data, related to the relapse of bronchiolitis obliterans organizing pneumonia (BOOP). Retrospective study. The medical files of Fukuoka University Hospital and Nishi Fukuoka Hospital patients from 1984 to 1996 were reviewed, and 18 cases of BOOP that had been diagnosed using transbronchial or open lung biopsy were selected for evaluation. The 18 cases were put into two groups composed of 7 patients who relapsed and 11 who did not relapse. Their clinical symptoms and laboratory data at first admission, including hemograms, blood chemistry tests, and pulmonary function tests were compared. Patients with or without associated diseases, such as collagen vascular diseases, were compared using the same parameters in order to examine the relationship between the associated diseases and BOOP relapse. The serum levels of total protein and albumin in patients who relapsed were significantly lower than in patients who did not relapse, respectively: 5.8 (range, 4.4 to 6.2) vs 6.3 (range, 4.5 to 6.8) g/dL, p < 0.05; and 2.9 (range, 2.5 to 3.4) vs 3.7 (range, 2.8 to 4.3) g/dL, p < 0.01. Levels of serum albumin in BOOP patients with associated diseases, however, were significantly lower than in those without associated diseases, respectively: 2.95 (range, 2.5 to 3.9) vs 3.65 (range, 2.8 to 4.3) mg/dL, p < 0.05. The fall in serum albumin levels in patients who relapsed, therefore, was probably due to associated diseases. The fact that 5 of 8 patients with associated diseases relapsed but only 2 of 10 without associated diseases relapsed suggests that a relationship exists between associated diseases and the prognosis of BOOP, although this finding was not statistically significant because of the small number of cases and the heterogeneity of the associated diseases. The most striking observation was that Pao2 levels in patients who relapsed were significantly lower than in those who did not, respectively: 55.4 (range, 39.9 to 73.2) vs 78.0 (range, 48.4 to 89.4) mm Hg, p < 0.05. However, Pao2 levels were not statistically different between patients with and without associated diseases, respectively: 66.0 (range, 45.4 to 78.8) vs 71.4 (range, 39.9 to 89.4) mm Hg. The severity of hypoxemia at first medical examination may be an important determinant for the subsequent BOOP relapse." @default.
• W2080734587 created "2016-06-24" @default.
• W2080734587 creator A5015638005 @default.
• W2080734587 creator A5040761742 @default.
• W2080734587 creator A5051878712 @default.
• W2080734587 creator A5055059649 @default.
• W2080734587 creator A5063947250 @default.
• W2080734587 creator A5072680416 @default.
• W2080734587 date "1998-12-01" @default.
• W2080734587 modified "2023-10-09" @default.
• W2080734587 title "Factors Related to the Relapse of Bronchiolitis Obliterans Organizing Pneumonia" @default.
• W2080734587 cites W1976530706 @default.
• W2080734587 cites W2036005603 @default.
• W2080734587 cites W2041775285 @default.
• W2080734587 cites W2047460886 @default.
• W2080734587 cites W2065541109 @default.
• W2080734587 cites W2074661933 @default.
• W2080734587 cites W2161522565 @default.
• W2080734587 cites W2167431323 @default.
• W2080734587 cites W3025576394 @default.
• W2080734587 cites W4232198072 @default.
• W2080734587 cites W4246107242 @default.
• W2080734587 cites W4254397249 @default.
• W2080734587 doi "https://doi.org/10.1378/chest.114.6.1599" @default.
• W2080734587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9872195" @default.
• W2080734587 hasPublicationYear "1998" @default.
• W2080734587 type Work @default.
• W2080734587 sameAs 2080734587 @default.
• W2080734587 citedByCount "52" @default.
• W2080734587 countsByYear W20807345872012 @default.
• W2080734587 countsByYear W20807345872013 @default.
• W2080734587 countsByYear W20807345872014 @default.
• W2080734587 countsByYear W20807345872015 @default.
• W2080734587 countsByYear W20807345872016 @default.
• W2080734587 countsByYear W20807345872017 @default.
• W2080734587 countsByYear W20807345872018 @default.
• W2080734587 countsByYear W20807345872019 @default.
• W2080734587 countsByYear W20807345872020 @default.
• W2080734587 countsByYear W20807345872022 @default.
• W2080734587 countsByYear W20807345872023 @default.
• W2080734587 crossrefType "journal-article" @default.
• W2080734587 hasAuthorship W2080734587A5015638005 @default.
• W2080734587 hasAuthorship W2080734587A5040761742 @default.
• W2080734587 hasAuthorship W2080734587A5051878712 @default.
• W2080734587 hasAuthorship W2080734587A5055059649 @default.
• W2080734587 hasAuthorship W2080734587A5063947250 @default.
• W2080734587 hasAuthorship W2080734587A5072680416 @default.
• W2080734587 hasConcept C126322002 @default.
• W2080734587 hasConcept C141071460 @default.
• W2080734587 hasConcept C165616093 @default.
• W2080734587 hasConcept C167135981 @default.
• W2080734587 hasConcept C2776125364 @default.
• W2080734587 hasConcept C2776739411 @default.
• W2080734587 hasConcept C2777677276 @default.
• W2080734587 hasConcept C2777714996 @default.
• W2080734587 hasConcept C2777914695 @default.
• W2080734587 hasConcept C2781448352 @default.
• W2080734587 hasConcept C71924100 @default.
• W2080734587 hasConcept C75603125 @default.
• W2080734587 hasConcept C90924648 @default.
• W2080734587 hasConceptScore W2080734587C126322002 @default.
• W2080734587 hasConceptScore W2080734587C141071460 @default.
• W2080734587 hasConceptScore W2080734587C165616093 @default.
• W2080734587 hasConceptScore W2080734587C167135981 @default.
• W2080734587 hasConceptScore W2080734587C2776125364 @default.
• W2080734587 hasConceptScore W2080734587C2776739411 @default.
• W2080734587 hasConceptScore W2080734587C2777677276 @default.
• W2080734587 hasConceptScore W2080734587C2777714996 @default.
• W2080734587 hasConceptScore W2080734587C2777914695 @default.
• W2080734587 hasConceptScore W2080734587C2781448352 @default.
• W2080734587 hasConceptScore W2080734587C71924100 @default.
• W2080734587 hasConceptScore W2080734587C75603125 @default.
• W2080734587 hasConceptScore W2080734587C90924648 @default.
• W2080734587 hasIssue "6" @default.
• W2080734587 hasLocation W20807345871 @default.
• W2080734587 hasLocation W20807345872 @default.
• W2080734587 hasOpenAccess W2080734587 @default.
• W2080734587 hasPrimaryLocation W20807345871 @default.
• W2080734587 hasRelatedWork W1997835440 @default.
• W2080734587 hasRelatedWork W1999147557 @default.
• W2080734587 hasRelatedWork W2009752954 @default.
• W2080734587 hasRelatedWork W2030689110 @default.
• W2080734587 hasRelatedWork W2035492660 @default.
• W2080734587 hasRelatedWork W2080914862 @default.
• W2080734587 hasRelatedWork W2118019621 @default.
• W2080734587 hasRelatedWork W2130088358 @default.
• W2080734587 hasRelatedWork W246796895 @default.
• W2080734587 hasRelatedWork W2740726438 @default.
• W2080734587 hasVolume "114" @default.
• W2080734587 isParatext "false" @default.
• W2080734587 isRetracted "false" @default.
• W2080734587 magId "2080734587" @default.
• W2080734587 workType "article" @default.